Skip to main content

Zimmer Biomet Holdings Value Stock - Dividend - Research Selection

Zimmer

ISIN: US98956P1021 , WKN: 753718

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through four segments: Spine, less Asia Pacific; Office Based Technologies; Craniomaxillofacial and Thoracic; and Dental. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products; and bone cement and spinal fusion stimulators. The company\'s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


UBS: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Is A Bottom-Ranked Quant Stock

2024-11-16
We recently made a list of UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors. In this piece, we will look at where Zimmer Biomet Holdings, Inc. (NYSE:ZBH) ranks on the list of UBS’ bottom quant stocks. With November 2024 having settled in and the US presidential election in […]

Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer

2024-11-13
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced a partnership with Arnold Schwarzenegger, who will take on the newly established role of Chief Movement Officer. In this strategic role, Schwarzenegger will collaborate closely with Zimmer Biomet to motivate, engage and support individuals to increase mobility, maintain joint health and proactively incorporate movement into their daily routines to foster overall health and wellness.

ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues

2024-11-11
Zimmer Biomet expects ROSA and Persona Cementless Knee to enhance its robotics and cementless market penetration to 50% to 60% range at a rapid pace.

Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors

2024-11-07
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors

Zimmer Biomet to Present at Jefferies London Healthcare Conference

2024-11-07
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Jefferies London Healthcare Conference on November 19, 2024, with a fireside chat at 11:00 a.m. GMT (6:00 a.m. ET).

Zimmer Biomet Holdings Inc. stock rises Wednesday, still underperforms market

2024-11-06
Zimmer Biomet Holdings Inc. stock rises Wednesday, still underperforms market

Zimmer Biomet Holdings Inc. stock rises Tuesday, still underperforms market

2024-11-05
Zimmer Biomet Holdings Inc. stock rises Tuesday, still underperforms market

NeuroOne agree $3m partnership with Zimmer Biomet

2024-11-04
The deal between the two healthcare firms will see Zimmer Biomet distributing the OneRF system which is designed to treat brain conditions such as seizures.

Zimmer licenses NeuroOne brain ablation system

2024-11-04
NeuroOne will get $3 million upfront for an exclusive license to distribute its radiofrequency ablation system designed to treat neurological disorders such as epilepsy and Parkinson's disease.

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day

2024-11-04
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day